M Keating Selected Research

M Keating Research Topics

Disease

12	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018 - 03/2000
11	Neoplasms (Cancer) 01/2018 - 01/2000
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 06/2007 - 02/2000
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2007 - 09/2000
5	Leukemia 01/2018 - 02/2000
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2007 - 01/2000
3	Lymphoma (Lymphomas) 01/2018 - 06/2000
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2002 - 12/2000
2	Hematologic Neoplasms (Hematological Malignancy) 03/2007 - 04/2001
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 09/2000 - 02/2000
1	Pleural Effusion (Pleural Effusions) 07/2017
1	Chromosome Aberrations (Chromosome Abnormalities) 09/2002
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2002
1	Lymphocytosis 12/2001
1	Cytopenia 10/2001
1	Anemia 10/2001
1	Pure Red-Cell Aplasia 10/2001
1	Thrombocytopenia (Thrombopenia) 10/2001
1	Wounds and Injuries (Trauma) 08/2001
1	Burns 08/2001
1	Hepatomegaly 07/2001
1	Splenomegaly 07/2001
1	Mucositis 07/2001
1	Philadelphia Chromosome 04/2001
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2001
1	Neoplasm Metastasis (Metastasis) 04/2001
1	Infections 03/2001
1	Pneumonia (Pneumonitis) 03/2001
1	Sepsis (Septicemia) 03/2001
1	Neutropenia 03/2001
1	Prolymphocytic Leukemia 12/2000
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2000
1	Necrosis 09/2000
1	Ataxia Telangiectasia (Louis Bar Syndrome) 03/2000
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2000

Drug/Important Bio-Agent (IBA)

3	Hemoglobins (Hemoglobin)IBA 07/2017 - 07/2001
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2001 - 07/2000
2	Proteins (Proteins, Gene)FDA Link 06/2007 - 07/2001
2	Cyclin D1IBA 09/2002 - 06/2000
2	fludarabineIBA 10/2001 - 03/2001
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 08/2001 - 09/2000
2	Pharmaceutical PreparationsIBA 07/2001 - 12/2000
2	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2001 - 02/2000
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 04/2001 - 09/2000
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2001 - 02/2000
1	Interleukin-15 (Interleukin 15)IBA 01/2018
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2018
1	Chimeric Antigen ReceptorsIBA 01/2018
1	ibrutinibIBA 01/2018
1	Syndecan-1 (Syndecan 1)IBA 02/2009
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 06/2007
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2007
1	DNA (Deoxyribonucleic Acid)IBA 01/2003
1	N 30IBA 12/2001
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2001
1	angiogeninIBA 08/2001
1	EnzymesIBA 08/2001
1	TransCyteIBA 08/2001
1	Daunorubicin (Cerubidine)FDA LinkGeneric 07/2001
1	acivicin (AT 125)IBA 07/2001
1	Glycoproteins (Glycoprotein)IBA 07/2001
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2001
1	Interferon-alpha (Interferon Alfa)IBA 04/2001
1	Rituximab (Mabthera)FDA Link 12/2000
1	Monoclonal AntibodiesIBA 12/2000
1	CD20 AntigensIBA 12/2000
1	Transforming Growth Factor alpha (TGF-alpha)IBA 09/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2000
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2000
1	Ataxia Telangiectasia Mutated ProteinsIBA 03/2000
1	Topoisomerase I InhibitorsIBA 02/2000
1	Topotecan (Hycamtin)FDA LinkGeneric 02/2000
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2000

Therapy/Procedure

7	Therapeutics 03/2007 - 10/2000
2	Combination Drug Therapy (Combination Chemotherapy) 04/2001 - 03/2001
1	Immunomodulation 01/2018
1	Ligation 11/2010
1	Length of Stay 08/2001
1	Artificial Skin 08/2001